For Gilead Science (GILD) develop and explain an IFE, BCG matrix, Grand Strategy

Question

For Gilead Science (GILD) develop and explain an IFE, BCG matrix, Grand Strategy Matrix, and QSPM.

Gilead Sciences is a research-based biopharmaceutical company that was founded with a vision of advancing therapeutics for life-threatening diseases worldwide. Today the company is a leading biopharmaceutical company, fulfilling their vision by discovering, developing and commercializing antiviral drugs used in the treatment of HIV/AIDs, hepatitis C, Hepatitis B, influenza, liver disease and serious cardiovascular and respiratory conditions.

Headquartered and founded in Foster City, California, Gilead has operations in North America, Europe and Australia with approximately 9,000 employees. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Currently, the company is trading on Nasdaq around $73 USD a share.

Competitive Analysis

Gilead's products mainly compete with other antiviral drugs commercialized by a number of other companies and institutions around the world. Due to the nature of the industry, Gilead's drugs compete with other available products in areas such as effectiveness, safety, ease of use, doctor acceptance, price, and insurance coverage. For Gilead, competition in the pharmaceutical industry differs depending on the area of treatment and the specific drug benefits. For example, each drug manufactured by Gilead, the company has different competitors. That being said, based on the companies product segments Gilead has differing levels of market share when compared to their competitors:

(Markets share per company) (https://csimarket.com/stocks/competitionSEG2.php?code=GILD)

For HIV Related Products:

Gilead (GILD) – 16.28%

Abbott Laboratories (ABT) – 2.12%

Bristol Meyers (BMY) – 4.68%

Abbvie Inc. (ABBV) – 1.29%

Abbott Lab (ABT) – 7.54%

Merck & Co. (MRK) – 2.89%

Liver Disease Medication:

Gilead (GILD): medicine called Sovaldi – 39.28%

Bristol Meyers (BMY): medicine called Baraclude – 20.78%

Abbvie Inc. (ABBV) : medicine called Viekira – 11.71%

Medicine for Cardiovascular Disease:

Gilead (GILD): medicine called Letairis – .97%

Pfizer (PFE): medicine not identified – 24.5%

Covidien LTD: medicine not identified – 2.76%

Based on the competitive analysis of different products carried by Gilead the numbers above show that they are a market leader for medicine focused on HIV and liver disease but Pfizer is leading in the area of cardiovascular.

Strengths

Strong Brand Portfolio

Product Innovation and Development

Customer Satisfaction

Skilled Workforce

Weaknesses

Organizational structure limits growth opportunities

Financial planning and allocation

Strategy

Gilead Science is an established research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company seeks to improve the care of patients with life-threatening diseases around the world. This is done through the hundreds of clinical trials and continuous efforts in research and development programs that seek to identify treatments. As the company grows, management should continue to expand Gilead’s global presence by increasing access to their medications and provide support to the communities in which they operate around the world. They plan to do this through global access programs, partnerships with generic manufacturers, patient access programs within the US, and involvement in helping to expand screening processes.

Explanation / Answer

Human service organizations - According to essential services , services are available in time span and some services available 24 X 7. The services which are available 24 X 7 which include transportation & hospitality needs regular staff perform task. While performing this services many serving people become victim of accident and there future life become less prospective. Thus to protect the welfare of such employee certain special provision are made which will protect his employment as social security.

Barrier in implementation- If person get victim of accident & become temporary or permanent disable, then to help it require financial strong organization to bear his expenses. Thus rule and regulation differ according to capacity of organization . If organization is capable to bear cost incurred for compensation and continuation of employment in that case such rule are applicable but in case of organization not capable to bear financial bourdon in that case its unfortunate for employee to continue with that organization.

Cultural change- Culture of organizations differ according to its globe & stander norms. If organization is having separate employee welfare department, which is there for care for employee & care for his social benefit in that case immediate redressal of claim is possible. Thus Social insurance is device by which each employee accidental insouciance policy can be purchase which certainly help to minimum certain financial pressure. The government circular directly impact to understandings of people.

Employee awareness- employee awareness is useful and to boost employee awareness it require proper communication . If certain norms for employee welfare made compulsory in that case, unfortunately employee become victim of any accidental situation, this will not spoil whole family life for want of financial requirement. Also some sensitive issue attached with is that to purchase insurance policy for partner may develop certain doubt for existence of malice. To avoid this Its responsibility that each individual must reserve some fund self so that in case of any abnormal condition arose this fund will help him support for financial to him or his family ..

Related Questions

Navigate

• Browse (All)
• Browse F
• Subjects

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.